Eight years later, FDA revises draft guidance on pediatric clinical pharmacology studies
The FDA on Wednesday released updated draft guidance focusing on how sponsors of new drugs and biologics can best identify the appropriate pediatric doses of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
